Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Diabetes Metab J 2025;49:333-47
Outcomes were collected in relation to weight reduction, prevention of weight gain, resolution or prevention of metabolic comorbidities including hyperinsulinemia, dyslipidaemia, and hypertension, as well as biomarkers of obesity-related inflammation
Semaglutide injection for weight management
Our Locations West Des Moines, IA 6420 Coachlight Dr #200, West Des Moines, IA 50266 (515) 221-4905
Further Reading [1] Eli Lilly and Company, 'Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial', Investor press release, May 2026
US$ 23.72
US$ 20.05
US$ 27.00
US$ 20.08
